PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,228,334 | -20.9% | 105,226 | +3.3% | 0.08% | -19.0% |
| Q2 2023 | $4,083,494 | +25.5% | 101,909 | +27.8% | 0.10% | +18.0% |
| Q1 2023 | $3,254,557 | +17.5% | 79,749 | +11.2% | 0.09% | +2.3% |
| Q4 2022 | $2,770,159 | -8.3% | 71,747 | +26.3% | 0.09% | -5.4% |
| Q3 2022 | $3,022,000 | -42.4% | 56,809 | -36.9% | 0.09% | -39.9% |
| Q2 2022 | $5,245,000 | -43.5% | 89,962 | -26.0% | 0.15% | -35.7% |
| Q1 2022 | $9,276,000 | +10.0% | 121,541 | -13.3% | 0.24% | +11.2% |
| Q4 2021 | $8,434,000 | +80.5% | 140,173 | +68.0% | 0.21% | +63.4% |
| Q3 2021 | $4,673,000 | +24.6% | 83,448 | +35.0% | 0.13% | +19.1% |
| Q2 2021 | $3,751,000 | -3.2% | 61,811 | +11.8% | 0.11% | -12.7% |
| Q1 2021 | $3,874,000 | +42944.4% | 55,277 | +26996.6% | 0.13% | – |
| Q4 2019 | $9,000 | +12.5% | 204 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 204 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | – | 204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |